tiprankstipranks
SBI Life Insurance Co. Ltd. (IN:SBILIFE)
:SBILIFE
India Market
Want to see IN:SBILIFE full AI Analyst Report?

SBI Life Insurance Co. Ltd. (SBILIFE) AI Stock Analysis

5 Followers

Top Page

IN:SBILIFE

SBI Life Insurance Co. Ltd.

(SBILIFE)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
₹2,090.00
▲(12.51% Upside)
Action:Reiterated
Date:08/04/26
The score is driven primarily by strong financial fundamentals (debt-free balance sheet, solid ROE, and excellent cash conversion) and supported by constructive price momentum. These positives are meaningfully offset by expensive valuation (very high P/E) and a minimal dividend yield, which increases sensitivity to any slowdown given thin margins and revenue volatility.
Positive Factors
Debt-free balance sheet
A debt-free balance sheet gives SBI Life financial flexibility to support policy growth, absorb experience volatility, and invest in distribution or products without significant financing pressure. Steadily growing equity also strengthens the capital base supporting long-duration insurance obligations.
Negative Factors
Volatile revenue growth
The sharp revenue decline followed by a rebound shows that SBI Life’s top-line progression has not been consistently smooth. Such volatility can make operating planning and earnings forecasting more difficult, particularly if growth depends on changing product or premium mix.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
A debt-free balance sheet gives SBI Life financial flexibility to support policy growth, absorb experience volatility, and invest in distribution or products without significant financing pressure. Steadily growing equity also strengthens the capital base supporting long-duration insurance obligations.
Read all positive factors

SBI Life Insurance Co. Ltd. (SBILIFE) vs. iShares MSCI India ETF (INDA)

SBI Life Insurance Co. Ltd. Business Overview & Revenue Model

Company Description
SBI Life Insurance Company Limited functions as a private life insurer operating across India. The firm provides a broad portfolio of life and health coverage, tailored for both individual clients and group entities. Its offerings include particip...
How the Company Makes Money
SBI Life makes money primarily by underwriting and managing life insurance policies and earning income from premiums and the investment of those premiums. Key revenue/earnings drivers include: 1) Premium income and policy charges - Customers pay ...

SBI Life Insurance Co. Ltd. Financial Statement Overview

Summary
Strong overall financial quality supported by a debt-free balance sheet, steadily growing equity, and consistently healthy ROE (~12.7%–14.2%). Cash generation is a major positive with free cash flow closely tracking earnings (~0.99–1.00 conversion) and a strong rebound in FY2026. The key constraint is thin net margins (~1.4%–2.2%) and a volatile revenue path (notable FY2025 dip before recovery), which can reduce earnings resilience.
Income Statement
74
Positive
Balance Sheet
86
Very Positive
Cash Flow
90
Very Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue1.19T1.12T1.15T1.31T806.39B829.11B
Gross Profit749.35B575.41B1.12T1.28T775.77B807.53B
EBITDA26.72B25.37B25.90B20.27B18.51B16.58B
Net Income26.01B24.70B24.13B18.94B17.21B15.06B
Balance Sheet
Total Assets5.34T5.00T4.57T3.98T3.15T2.73T
Cash, Cash Equivalents and Short-Term Investments15.27B32.08B18.47B48.31B23.43B26.85B
Total Debt0.000.000.000.000.000.00
Total Liabilities5.14T4.81T4.40T3.83T3.02T2.62T
Stockholders Equity201.21B190.86B169.85B149.09B130.17B116.22B
Cash Flow
Free Cash Flow144.85B343.38B254.40B290.07B416.52B336.26B
Operating Cash Flow145.78B345.23B255.47B291.22B417.15B336.82B
Investing Cash Flow-157.00B-353.18B-217.89B-312.21B-302.03B-216.11B
Financing Cash Flow404.20M-1.79B-2.15B-2.27B-4.15B-2.31B

SBI Life Insurance Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1857.65
Price Trends
50DMA
1811.94
Negative
100DMA
1815.81
Negative
200DMA
1903.72
Negative
Market Momentum
MACD
-30.31
Positive
RSI
32.53
Neutral
STOCH
12.69
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SBILIFE, the sentiment is Negative. The current price of 1857.65 is above the 20-day moving average (MA) of 1761.55, above the 50-day MA of 1811.94, and below the 200-day MA of 1903.72, indicating a bearish trend. The MACD of -30.31 indicates Positive momentum. The RSI at 32.53 is Neutral, neither overbought nor oversold. The STOCH value of 12.69 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SBILIFE.

SBI Life Insurance Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹5.19T8.582.46%10.53%23.28%
71
Outperform
₹842.87B110.9138.00%96.70%
69
Neutral
₹1.71T64.940.16%-0.43%4.44%
58
Neutral
₹1.16T56.110.78%5.03%4.87%
57
Neutral
₹680.75B39.500.36%-8.37%35.27%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
52
Neutral
₹521.12B458.910.63%4.89%-59.23%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SBILIFE
SBI Life Insurance Co. Ltd.
1,685.00
-125.73
-6.94%
IN:HDFCLIFE
HDFC Life Insurance Co. Ltd.
514.35
-257.30
-33.34%
IN:ICICIPRULI
ICICI Prudential Life Insurance Co. Ltd.
460.00
-136.43
-22.87%
IN:LICI
Life Insurance Corp. of India
407.30
-21.08
-4.92%
IN:MFSL
Max Financial Services Limited
1,461.10
-144.95
-9.03%
IN:POLICYBZR
PB Fintech Limited
1,799.30
-12.25
-0.68%

SBI Life Insurance Co. Ltd. Corporate Events

SBI Life to Engage Investors at Goldman Sachs Asia Leaders Conference 2026
Aug 26, 2026
SBI Life Insurance Company Ltd. has disclosed that its senior management will participate in the Goldman Sachs Asia Leaders Conference 2026 in Hong Kong on August 31 and September 1, 2026, engaging with investors and analysts. The company emphasiz...
SBI Life Plans Investor Meeting at Morgan Stanley India Financials Event
Aug 23, 2026
SBI Life Insurance Company Ltd. is a leading Indian life insurer offering a diversified portfolio of life insurance and protection solutions to retail and institutional clients. The company operates under IRDAI oversight and maintains a prominent ...
SBI Life announces board change as independent director completes tenure
Aug 19, 2026
SBI Life Insurance has announced that independent director Narayan K. Seshadri has stepped down from the board following the completion of his permitted tenure. His cessation, effective at the close of business on August 19, 2026, reflects routine...
SBI Life boosts paid-up capital with ESOP share allotment
Aug 18, 2026
SBI Life Insurance has allotted 88,522 equity shares to employees following the exercise of vested options under its 2018 Employee Stock Option Scheme, as approved by the Board Stakeholders’ Relationship and Sustainability Committee on Augus...
SBI Life details 26th AGM proceedings and reinforces governance focus
Aug 14, 2026
SBI Life Insurance Company Ltd. convened its 26th Annual General Meeting on August 14, 2026 via video conference and other audio-visual means, in compliance with the Companies Act, SEBI listing regulations and relevant government and regulatory ci...
SBI Life Shareholders Clear All Resolutions at Digitally Conducted AGM
Aug 14, 2026
SBI Life Insurance Company Ltd. held its 26th Annual General Meeting on August 14, 2026, via video conferencing and other audio-visual means, with e-voting provided to shareholders. The AGM was attended remotely by promoters and public shareholder...
SBI Life Confirms Fully Dematerialized Shareholding for June Quarter
Jul 10, 2026
SBI Life Insurance Company Ltd. has reported to the National Stock Exchange and BSE that its registrar and share transfer agent, KFin Technologies, has issued a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulat...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 04, 2026